Epitope mapping of Aleutian Mink Disease parvovirus virion protein VP1 and 2

Scandinavian Journal of Immunology

Volumn 49, Issue 4, 1999, Pages 347-354

  Costello, F ^a   Steenfos, N ^a   Jensen, K T ^a   Christensen, J ^a   Gottschalck, E ^a   Holm, A ^b   Aasted, B ^a,b  

^a Immunological Laboratory   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS PROTEIN;

ALEUTIAN MINK DISEASE; ARTICLE; GENE INSERTION; GENE MAPPING; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; VIRION;

ALEUTIAN MINK DISEASE; ALEUTIAN MINK DISEASE VIRUS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAPSID; CAPSID PROTEINS; EPITOPE MAPPING; FEMALE; IMMUNODOMINANT EPITOPES; MINK; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; VIRION;

EID: 0033041482     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00499.x     Document Type: Article

References (34)

1. Chapman MS, Rossman MG. Structure, sequence, and function correlations among parvovirus. Virology 1993;194:491-508.
2. Reed AP, Jones EV, Miller TJ. Nucleotide sequence and genome organization of canine parvovirus. J Virol 1988;62:266 76.
3. Aasted B, Aleutian disease of mink. Virology and immunology. Acta Path Microbiol Immunol Scand Section C 93 1985;Suppl. 287:1 47.
4. Aasted B. Mink infected with aleutian disease virus have an elevated level of CD8-positive T-lymphocytes. Vet Immunol Immunopathol 1989;20:375-85.
5. Porter DD, Larsen AE, Porter HG. Aleutian disease of mink. Adv Immunol 1980;29:261-86.
6. Aasted B, Alexandersen S, Christensen J. Vaccination with aleutian mink disease parvovirus (AMDV) capsid proteins enhances disease, while vaccination with the major non-structural AMDV protein causes partial protection. Vaccine 1998;16:1158-65.
7. Porter AD, Larsen AE, Porter HG. The pathogenesis of aleutian disease of mink. II. Enhancement of tissue lesions following the administration of a killed virus vaccine or passive antibody. J Immunol 1972;109:1-7.
8. Aasted B, Tierny GS, Bloom ME. Analysis of the quantity of antiviral antibodies from mink infected with different aleutian disease virus strains. Scand J Immunol 1984;19:395-402.
9. Porter DD, Porter HG, Larsen AE. Much of the increased IgG in aleutian disease of mink is viral antibody. J Exp Path 1984;1:463-6.
10. Aasted B, Leslie G. Virus-specific B-lymphocytes are probably the primary targets for aleutian disease virus. Vet Immunol Immuno-path 1991;28:127-41.
11. Tsao J, Chapman MS, Agbandje M et al. The three-dimensional structure of canine parvovirus and its functional implications. Science 1991;251:1456-64.
12. Wu H, Rossmann MG. The canine parvovirus empty capsid structure. J Mol Biol 1993;233:231-44.
13. Agbandje M, McKenna R, Rossmann MG, Strassheim ML, Parrish CR. Structure determination of feline panleukopenia virus empty particles. Proteins: Structure, Function, and Genetics 1993;16:155 71.
14. Agbandje M, Kajigaya S, McKenna R, Young NS, Rossmann M. The structure of human parvovirus B19 at 8 ǎ resolution. Virology 1994;203:106-15.
15. Strassheim ML, Gruenberg A, Veijalainen P, Sgro JY, Parrish CR. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology 1994;198:175 84.
16. Bloom ME, Alexandersen S, Perryman S, Lechner D, Wolfinbarger JB. Nuclcotide sequence and genomic organization of aleutian mink disease parvovirus (ADV): Sequence comparisons between a non-pathogenic and a pathogenic strain of ADV. J Virol 1988;62:2903 15.
17. Gottschalck E, Alexandersen S, Cohn A, Poulsen L, BlooM M, Aasted B. Nucleotide sequence analysis of aleutian mink disease parvovirus indicates multiple virus types. J Virol 1991;65:1534-42.
18. Langerveld JPM, Casal JI, Cortés E et al. Effective induction of neutralizing antibodies with the amino terminus of VP2 of canine parvovirus as a synthetic peptide. Vaccine 1994;12:1473-80.
19. Langerveld JPM, Casal JI, Osterhaus ADME et al. First peptide vaccine providing protection against viral infection in the target animal. Studies of canine parvovirus in dogs. J Virol 1994;o8:4506-13.
20. Cortés E, San Martin C, Langeveld J, Meloen R, Dalsgaard K, Vela C, Casal I. Topographical analysis of canine parvovirus virions and recombinant VP2 capsids. J Gen Virol 1993;74:2005-10.
21. Kawase M, Momodeda M, Young NS, Kajigaya S. Most of the VPI unique region of B19 parvovirus is on the capsid surface. Virology 1995;211:359-66.
22. Rosenfeld SJ, Yoshimoto K, Kajigaya S et al. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface. J Clin Invest 1992;89:2034-29.
23. Gottschalck E, Alexandersen S, Storgaard T, Bloom ME, Aasted B. Sequence comparison of non-structural genes of four different types of aleutian mink disease parvovirus indicates an unusual degree of variablity. Arch Virol 1994;138:213 31.
24. Bloom ME, Martin DA, Oie KL et al. Expression of aleutian mink disease parvovirus capsid proteins in defined segments: Localization of immunoreactive sites and neutralizing epitopes to specific regions. J Virol 1997;71:705-14.
25. Christensen J, Storgaard T, Bloch B, Alexandersen S, Aasted B. Expression of aleutian mink disease parvovirus proteins in a baculovirus-vector system. J Virol 1993;67:229-38.
26. Holm A, Meldal M. Multiple column peptide synthesis. 1989. In: Bayer E, Jung G, eds. Peptides. New York: Walter de Gruyter, 1989:208-10.
27. Meldal M, Bistaard Holm C, Boejesen G, Havsteen Jakobsen M, Holm A. Multiple column peptide synthesis. Part 2. Int J Peptide Protein Res 1993;41:250 60.
28. Aasted B, Alexandersen S, Cohn A, Hansen M. Counter current line absorption immunoelectrophoresis is an alternative diagnostic screening test to counter current immunoelectrophoresis in aleutian disease (AD) eradication programs. Acta Vet Scand 1986;27:410-20.
29. Parker JM, Guo D, Hodges RS. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and x-ray-derived accessible sites. Biochemistry 1986;25:5425-32.
30. Christensen J, Pedersen M, Aasted B, Alexandersen S. Purification and characterization of the major non-structural protein (NS-1) of aleutian mink disease parvovivus. J Virol 1995;69:1802-9.
31. Aasted B, Bloom ME. Sensitive radioimmune assay for measuring aleutian disease virus and antibody. J Clin Microbiol 1983;18:637 44.
32. Aasted B, Bloom ME. Mink with aleutian disease have high affinity antiviral antibodies. Scand J Immunol 1984;19:411-18.
33. Hiroyuki K, Wolfinbarger JB, Bloom ME. Identification of aleutian mink disease parvovirus transcripts in macrophages of infected adult mink. J Virol 1992;66:5305-12.
34. Alexandereen S, Hau J, Larsen S. Examination of aleutian disease virus in charge-shift crossed immunoelectrophoresis. Acta Path Microbiol Immunol Scand Sect B. 1984;92:331-34.